Insider filing · CBIO
Jonathan McNeill
President and COO
profile →
Crescent Biopharma, Inc.
CBIO · Healthcare · 5 filings in 24 months
ticker →
Jonathan McNeill sold $370K of Crescent Biopharma (CBIO)
Executed Jun 22, disclosed Jun 23, 1 day later.
Value, as filed
$370K
20,549 sh × $17.99
Executed
Jun 22
the trade date, as filed
Disclosed
Jun 23
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJonathan McNeill (President and COO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crescent Biopharma, Inc. (CBIO). The largest single filing was $370K of CBIO (20,549 sh × $17.99, as filed), executed Jun 22.
The name
CBIOHealthcare · Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→